McDermott + Bull has successfully placed Bradley Wilson as Chief Financial Officer at Adherium. In his role, Bradley will lead financial strategy, capital planning, and financial operations as the company expands its U.S. presence. He will partner closely with the CEO, Board, and commercial leadership to guide capital allocation and shape pricing and payer agreements that support growth in remote patient monitoring and value-based care.
Bradley brings healthcare finance leadership experience across digital health, specialty infusion, and fertility services. Most recently, he served as Chief Financial Officer at PursueCare, where he oversaw financial operations and revenue cycle management, improved reimbursement processes, and secured equity and debt financing. Previously, he served as Chief Financial Officer at FlexCare Infusion Centers, where he built an in-house accounting team, led financial due diligence for acquisitions, and worked with commercial payers on contracts and reimbursement rates. Earlier in his career, Bradley served as Senior Vice President of Finance at Inception Fertility, where he led financial planning and supported the launch of new clinics. He earned an MBA in Finance from the University of North Carolina and a Bachelor of Science from the University of Alabama at Birmingham.
Adherium is an international digital health company focused on respiratory care. Its Hailie® Smartinhaler® sensors and cloud-based platform track when patients use their inhalers and give care teams access to that information remotely. The technology helps providers assess medication adherence and manage care for patients with asthma and chronic obstructive pulmonary disease (COPD).
This executive search was completed by McDermott + Bull Partner Garrett Lipus, Partner Ken Dropiewski, and Director Dani Rone.